This study is a prospective, randomized controlled clinical trial designed to evaluate the efficacy of transcutaneous electrical stimulation (posterior tibial nerve stimulation, PTNS) in the treatment of overactive bladder (OAB) developing after stroke.
Primary Hypothesis: PTNS therapy will significantly improve OAB symptoms in post-stroke patients compared to standard care/sham stimulation.
Primary Outcome Measure: Change from baseline in Overactive Bladder Symptom Score (OABSS) and/or frequency of urgency episodes as assessed after 12 weeks of treatment."
Eligibility
Sex
FEMALE
Min age
40 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria:
* Female
* Age 40 to 70 years
* History of ischemic or hemorrhagic stroke at least 6 months before enrollment
* Presence of overactive bladder symptoms
* Ability to provide written informed consent
Exclusion Criteria:
* Age outside the study range
* Pregnancy or breastfeeding
* Active urinary tract infection
* Neurogenic conditions other than stroke affecting bladder function
* Inability to comply with study procedures
* Refusal or inability to provide informed consent
Primary outcome measure(s)
Change in daily frequency of urgency episodes — Baseline and at 12 weeks. Number of urgency episodes per 24 hours recorded in patient bladder diary.
Trial sites (1)
Facility
City
Region
Status
Kutahya Health Sciences University
Kütahya
Kütahya
More Kutahya Health Sciences University trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.